PhosPrint SA was honored with the 2026 Start-up Entrepreneurship Award
- 3 Μαΐ
- διαβάστηκε 1 λεπτά
🏆 PhosPrint SA was honored with the 2026 Start-up Entrepreneurship Award from the Athens Chamber of Commerce and Industry (ACCI)!
This distinction is of particular significance to all of us. The award was accepted by the company’s CEO and President, Dr. Ioanna Zergioti, who thanked the Athens Chamber of Commerce and Industry for this outstanding recognition and highlighted something that fills us with pride: PhosPrint SA’s innovative in vivo laser bioprinting platform was born from the research focus and vision of its co-founders, Dr. Ioanna Zergioti, Dr. Apostolos Klinakis, and Maria Pallidou—as a spin-off of the National Technical University of Athens—with the goal of reaching the entire world.
This is a particularly significant moment for us, as the first clinical trial in humans is beginning—one of the very few Phase I clinical studies being conducted in Greece—in collaboration with Laiko and Genimatas Hospitals. A proud moment for Greek science, Greek innovation, and Greek healthcare.
We thank the Athens Chamber of Commerce and Industry (ACCI) - ACCI | Athens Chamber of Commerce and Industry, our exceptional team, our clinical partners, the European Innovation Council and SMEs Executive Agency (EISMEA), our private investors, and everyone who believed in our vision from the very beginning.
The future of bioprinting starts here!
Σχόλια